[go: up one dir, main page]

PT1321471E - Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico - Google Patents

Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico

Info

Publication number
PT1321471E
PT1321471E PT03290605T PT03290605T PT1321471E PT 1321471 E PT1321471 E PT 1321471E PT 03290605 T PT03290605 T PT 03290605T PT 03290605 T PT03290605 T PT 03290605T PT 1321471 E PT1321471 E PT 1321471E
Authority
PT
Portugal
Prior art keywords
aceitable
perindopril
vision
pharmaceutical
new synthesis
Prior art date
Application number
PT03290605T
Other languages
English (en)
Inventor
Jean-Pierre Lecouve
Dubuffet Thierry
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PT1321471E publication Critical patent/PT1321471E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT03290605T 2003-03-12 2003-03-12 Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico PT1321471E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290605A EP1321471B1 (fr) 2003-03-12 2003-03-12 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
PT1321471E true PT1321471E (pt) 2005-07-29

Family

ID=8185877

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03290605T PT1321471E (pt) 2003-03-12 2003-03-12 Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico

Country Status (10)

Country Link
EP (1) EP1321471B1 (pt)
AR (1) AR043567A1 (pt)
AT (1) ATE294814T1 (pt)
DE (1) DE60300581T2 (pt)
DK (1) DK1321471T3 (pt)
ES (1) ES2240919T3 (pt)
MY (1) MY135359A (pt)
PT (1) PT1321471E (pt)
SI (1) SI1321471T1 (pt)
WO (1) WO2004083238A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1362864E (pt) 2003-06-30 2007-07-23 Servier Lab Novo processo de síntese do perindopril e dos seus sais aceitáveis do ponto de vista farmacêutico
DK1367061T3 (da) * 2003-06-30 2006-05-15 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
PT1367062E (pt) * 2003-07-31 2006-12-29 Servier Lab Novo processo de síntese do perindopril e dos seus sais aceitáveis do ponto de vista farmacêutico
SI1380590T1 (sl) 2003-08-29 2006-12-31 Servier Lab Postopek za sintezo perindoprila in njenih farmacevtsko sprejemljivih soli
ATE310012T1 (de) 2003-08-29 2005-12-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen
BRPI0614622A2 (pt) * 2005-08-12 2011-04-12 Lek Pharmaceuticals processo para a preparação de perindopril erbumina
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril

Also Published As

Publication number Publication date
SI1321471T1 (pt) 2005-08-31
DE60300581D1 (de) 2005-06-09
EP1321471A1 (fr) 2003-06-25
DK1321471T3 (da) 2005-08-29
MY135359A (en) 2008-03-31
WO2004083238A1 (fr) 2004-09-30
ES2240919T3 (es) 2005-10-16
DE60300581T2 (de) 2006-01-19
EP1321471B1 (fr) 2005-05-04
AR043567A1 (es) 2005-08-03
ATE294814T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
IS7948A (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
NO20055417D0 (no) Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor
ATE424395T1 (de) Aminoderivate als histone-deacetylase-inhibitoren
DE60333020D1 (de) Anzeigeeinrichtung des dünnen typs
DE602004031543D1 (de) Amidderivate
PT1245568E (pt) Derivados sulfonilo de aminoacidos e sua utilizacao enquanto inibidores da dipeptidil-peptidase iv (dpp iv)
DE60334100D1 (de) Rückspiegelanordnungen
DE60330372D1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
DE60201859D1 (de) Pharmazeutische Verwendung von N-Carbamoylazol-Derivate
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
DE60300011D1 (de) Perindoprilsalz und dieses enthaltende Arzneimittel
ATE308543T1 (de) Piperidinderivate
EE200200040A (et) Ketotifeeni sisaldav oftalmiline ravimkoostis
PT1321471E (pt) Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico
EP1585519A4 (en) HIGH CONCENTRATION OPIOID FORMULATIONS AND OPIOID DERIVATIVES
NO20030382D0 (no) Nye indolderivater og deres anvendelse som medikamenter
DE60336720D1 (de) Fluorsulfate von hexafluorisobutylen und dessen höheren homologen und deren derivaten
NO20043576L (no) Pharmaceutical formulation comprising melatonin
DK1467750T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende perindopril
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
DE602004022169D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate